ArticleFrontiers in oncology2021

Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting

Xi He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.